This inventor holds 3 USPTO granted patents. Top assignee: Musc Foundation for Research Development. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Suraj K Dixit: Innovator in Organ Transplantation
Introduction
Suraj K Dixit is a prominent inventor based in Charleston, SC (US). He has made significant contributions to the field of organ transplantation through his innovative research and development of new formulations and methods. With a total of 3 patents to his name, Dixit is dedicated to improving the outcomes of transplant procedures.
Latest Patents
Dixit's latest patents include a groundbreaking formulation for donor organ pre-treatment. This formulation is designed to pre-treat an organ prior to transplantation, comprising a therapeutically effective amount of an immunosuppressive agent encapsulated in a micelle, liposome, or polymeric nanoparticle that features a targeting moiety on its surface. Another notable patent involves targeted nanocarriers for the administration of immunosuppressive agents. This innovation focuses on a nanocarrier containing an immunosuppressive agent that is specifically targeted to C3 breakdown products, integrin, or a combination thereof. This approach aims to reduce the harmful systemic effects of the immunosuppressive agent and provides a method for suppressing an allo-immune response in subjects undergoing allograft transplantation.
Career Highlights
Suraj K Dixit is currently associated with the MUSC Foundation for Research Development, where he continues to advance his research in organ transplantation. His work is characterized by a commitment to enhancing the safety and efficacy of transplant procedures.
Collaborations
Dixit collaborates with esteemed colleagues, including Ann-Marie Broome and Satish N Nadig, who contribute to his research efforts and innovations in the field.
Conclusion
Suraj K Dixit is a dedicated inventor whose work in organ transplantation is paving the way for improved medical outcomes. His innovative patents reflect his commitment to advancing healthcare through research and development.
